ZOETIS Jefferies Global Healthcare Conference
Review the key takeaways and the transcript of this earnings call.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Thanks, everyone, for joining. We have Jay Saccaro, CFO and COO of Zoetis, here with us today. Thanks for coming to London.
Yeah, thanks so much for having us. We appreciate it. And thanks to those joining us in these tight quarters. We appreciate you all taking time out of your day to learn more about our company.
Yeah. We have 25 minutes, a lot to get into. Maybe just start with kind of your first 90 days or so. You've been there, you've been meeting some customers. It's just helpful to understand where you're spending most of your time, how you're getting up to speed, and maybe just what surprised you the most in your initial 90 days versus what you observed from the outside.
Here's the good news. The good news is no real surprises. When I joined the company, I believe that this is a great company whose best days are ahead of it. And the reason I believe that, we have a great leadership and management team. We have an incredible pipeline, incredible commercial organization, and manufacturing and supply chain organization. We have so many great assets that my view was the opportunity to unlock value was there and that we would be able to do this in the coming years. For me, coming in, so many of the things I've seen have been confirmatory. I'm spending a lot of my time really understanding the financials, understanding the business, understanding the manufacturing processes and our customers, also digging into the pipeline in great depth.
And what I can tell you is all of that work has generally confirmed some of those initial theories, which is just really nice to see.
Okay. That's helpful. Kind of follow-up to that in terms of, given what you've seen, where do you think the biggest opportunities are at Zoetis? I think there's been some commentary about the commercial effectiveness. You mentioned the cost structure. Just where you kind of see the lowest hanging fruit.
Sure. I think that the biggest opportunity that we have is innovation in the pipeline. We have the opportunity with respect to our existing markets to launch differentiated product offerings based on new science and to enter completely new areas based on the pipeline work that we've done. I think that's a huge opportunity. Now, having said that, we're a world-class manufacturer and supplier of products, so I think we have a great opportunity in terms of continuing to drive down the manufacturing costs of the product that we make on a daily basis. Then finally, as I said, we have a really good commercial footprint. We sell in over 100 countries around the world, and we have outstanding relationships with all of our major customers.
From our standpoint, really taking advantage of that commercial organization and being very thoughtful about the promotions that we pursue, that's another real opportunity for us. But make no mistake, the biggest thing for us as we look to the future years comes down to this pipeline.
Okay. I want to pivot to the macro, I guess, which is a hot topic for a lot of people. I think it would just be helpful to kind of level set what you are hearing from the clinics, what you are hearing from pet owners. We are kind of coming off of this pandemic cycle and just kind of understanding where you think we are in the cycle, and just the macro environment in general would kind of be helpful to just start there.
Sure. Maybe before we get into some specific short-term dynamics, the one thing I would say is, during our earnings call, we pointed out a couple of interesting things with the Human Animal Bond Research Institute, some of the work that had been done there. It turns out that 98% of pet owners point to their pets contributing positively to their emotional or physical well-being. Okay? It is a huge deal. By the way, as a dog owner, when I see pictures of my dog, it makes me happy. Okay? Of those people, 91% said they would be willing to spend on their pet's health because of these benefits that they feel that they are receiving. Now, I know you are not a pet owner yet. I have hopes for you. Okay? I do. I have hopes for you.
The reality is, you have this great long-term tailwind, which is owning pets is a great thing. By the way, there is a second dynamic too, which is, if I were to ask the room a question, what percent of the people had a protein shake today or is focused on their protein consumption at some point during the day, I will tell you, I think everybody in the room would raise their hand. There is a long-term tailwind supporting protein consumption. You put these two tailwinds together, and overall, the story with respect to our two lines of business is solid. Now, we are seeing some pressure in the short term, and we have discussed this extensively. There are a few things, right? The veterinary service cost is up, I believe, 40% or 50% since 2022. So it is a very big increase in the cost to serve.
In addition to that, you have a willingness amongst Gen Z and millennials to switch how they get their products, be it channel, be it service provider, creating some intensity there. At the same time, homeowner affordability is another questionable area where there has been some pressure. What that is leading to is, in some cases, smaller homes, which leads to things like cat purchases versus dog purchases. You could get a cat, because you live in an apartment in Manhattan. But the point is, cats are under-medicalized relative to dogs, and so you have that phenomena as well. So there are a few factors that are in play that we have to be mindful of, but I get back to, what are the major tailwinds supporting this business? They are very big, right? This human-animal bond thing is enormous, and this idea around protein consumption.
These two tailwinds, I think, are inexorable, unignorable, and they will continue to drive the business going forward. In the meantime, we have seen some pressure, and I am sure we will talk about visit metrics and things of that nature, that we have seen some pressure on these things. We watch this very closely, and importantly, as we think about things like our guidance, we are not assuming any changes to these dynamics. We are not counting on a change in trajectory. We are going to assume this pressured environment continues. Generally speaking, I do believe there is cause for hope because of some of these things that I have mentioned.
Okay. That is helpful. I think maybe focusing on the short-term kind of pocket, talking to the pressure, I think in 3Q, you guys ran some targeted promos, some price investments. I think it would just be helpful to kind of hear what worked, maybe what did not work as well as you would like, how you are trying to change it in 4Q and beyond, just to try to navigate today's environment a little bit better.
Sure. It has been a fairly intense competitive environment, and what we have seen at the highest level in the third quarter, our price was down 1 point, maybe a little bit more than 1 point, and volume was flat, which in a challenging market with a competitive landscape that we are seeing, that is not a bad outcome. In fact, from a revenue standpoint, we came in where we hoped to be, perhaps a little bit better. Overall, things were moving ahead according to our expectations. Generally, our promotional strategy worked. What we did, for the most part, our promotions were focused on temporary rebates, discounts, incentives, either for customers or vets to trigger purchases. There were a couple of instances where we made a permanent price adjustment to products.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.
View the full transcript with ProCall participants
2 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
